Annaly Capital Management, Inc. vs Natera Inc. Common Stock — how do they compare? Annaly Capital Management, Inc. trades at $18.31 (market cap $13.69B), while Natera Inc. Common Stock trades at $392.78 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 4.2× Annaly Capital Management, Inc.'s market cap, and Annaly Capital Management, Inc. pays a 16.52% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Annaly Capital Management, Inc. for 92 Days and Natera Inc. Common Stock for 0 Days on average.
| NLY | NTRA | |
|---|---|---|
Market Cap | $13.69B | $57.03B |
Volume | 10,312,599 | 1,131,157 |
Sector | Real Estate | Health |
52-Week High | $24.40 | $425.64 |
52-Week Low | $17.93 | $179.42 |
Typical Hold Time | 92 Days | 0 Days |
Enterprise Value | $135.72B | $56.18B |
Dividend Yield | 16.52% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Annaly Capital Management Inc is an American mortgage real estate investment trust. The company segments its operations into Residential and Commercial real estate investments. While Annaly's Residential assets are primarily comprised of agency mortgage-backed securities and debentures, it is primarily invested in commercial mortgage loans and mortgage-backed securities in its Commercial unit through its subsidiary, Annaly Commercial Real Estate Group. Agency mortgage-backed securities and debentures make up the majority of the company's overall portfolio. Most of the company's counterparties are located in the U.S. Annaly generates nearly all of its revenue from the spread between interest earned on its assets and interest payments made on its borrowings.
Read more on NLY →Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →